The increase in price target by Piper Sandler suggests a positive outlook on Viatris's future performance, which could lead to investor optimism and a potential short-term increase in the stock price. However, the Neutral rating indicates that the analyst does not see significant outperformance relative to the market or sector, which tempers the potential impact.